THURSDAY, April 27, 2023 (HealthDay News) — Walking your dog gets you moving and out in the fresh air, but head injuries and fractures are very real possibilities, especially for older dog owners, researchers say. The most common injury from walking a leashed dog that sends folks to the ERContinue Reading
THURSDAY, April 13, 2023 (HealthDay News) — It sounds like the stuff of a vampire novel, but for people with a group of rare genetic disorders, exposure to sunlight can cause excruciating pain. Now, an experimental medication is showing promise for helping them better tolerate the light of day. InContinue Reading
WEDNESDAY, April 12, 2023 (HealthDay News) — Financial stress and work lost to cancer treatment affects patients and their partners alike. Partners also experienced pain, fatigue and sleep issues owing to these fiscal worries, a new study found. “We know that financial toxicity or hardship is a significant effect ofContinue Reading
MONDAY, April 10, 2023 (HealthDay News) — Put out that cigarette for the health of your four-legged friend. When smokers search social media for anti-tobacco information, they tend to engage most with posts about the risk of secondhand smoke on their pets, a new study reveals. Posts with new informationContinue Reading
WEDNESDAY, April 5, 2023 (HealthDay News) — A therapy that bolsters the immune system may not only help certain cancer patients live longer, but better, a new study finds. The treatment, called chimeric antigen receptor (CAR) T-cell therapy, is used to fight certain types of blood cancer — including leukemiaContinue Reading
TUESDAY, April 4, 2023 (HealthDay News) — Monoclonal antibodies have been an effective tool in the battle against COVID-19, reducing the risk of hospitalization or death by 39% for people who started the treatment within two days of a positive test, a new study finds. These treatments were even moreContinue Reading
MONDAY, April 3, 2023 (HealthDay News) — An experimental targeted drug could provide a fresh chance for people with recurring head and neck cancer that has grown resistant to other treatments, a new clinical trial says. Ficlatuzumab used in combination with the already approved targeted drug cetuximab (Erbitux) significantly improvedContinue Reading
FRIDAY, March 31, 2023 (HealthDay News) — Cats constantly licking and chewing because of a skin condition called feline allergic dermatitis may benefit from a new generic treatment approved by the U.S. Food and Drug Administration. The FDA approved Modulis for Cats on March 29, making it the first genericContinue Reading
THURSDAY, March 30, 2023 (HealthDay News) — While research has shown that having pets can lower the chances of respiratory allergies in children, a new study finds it might also reduce the risk of food allergies. Japanese investigators found that young children exposed to dogs in the home were lessContinue Reading
FRIDAY, March 24, 2023 (HealthDay News) — While losing a spouse can shorten anyone’s life, new Danish research suggests widowers may be far more vulnerable than widows. After six years spent tracking health outcomes among nearly 925,000 Danish seniors, investigators determined that when a man between the ages of 65Continue Reading